Genetics News

PARIS--(BUSINESS WIRE)--Regulatory News: The 15-20 National Hospital (l’Hôpital national des 15-20) in Paris and GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced that the first patients have been treated in the French Named Patient Early Access Program (AAC) for GS010/LUMEVOQ®.1 The REVISE...

SEATTLE--(BUSINESS WIRE)--Fertio, an international fertility care group and parent company of European Sperm Bank, announced today its expansion into the United States through the acquisition of Cascade Cryobank, a Lynwood, WA sperm bank founded in 2021 by Dr. John Carpenter. This strategic move unites Fertio’s 20+ years of global expertise with Cascade’s innovative early donor disclosure program, advancing fertility care and family-building options for U.S. parents. Cascade Cryobank, as part o...

NEW YORK--(BUSINESS WIRE)--Serial Biotech Entrepreneur, Cathy Tie, today announced the launch of Origin Genomics, a New York–based company dedicated to advancing precision germline gene correction for severe inherited diseases. The company launch follows the constructive conclusion of Manhattan Genomics. Cathy Tie is now launching the next chapter of her work, continuing to advance responsible genomic medicine. Origin Genomics will operate exclusively in the United States, with research conduct...

SAN DIEGO--(BUSINESS WIRE)--n-Lorem publishes commentary titled ‘Establishing a Commercial Solution for Extremely Rare Genetic Diseases’ in Nature Biotechnology....

NEW YORK--(BUSINESS WIRE)--Diadia Health has officially launched its AI causal reasoning platform nationwide following successful beta validation across 12+ clinical sites and thousands of patient cases. The platform analyzes genetic variants and lab results to help clinicians identify potential root causes in complex chronic disease cases and generate personalized treatment recommendations with 60% less trial-and-error than standard protocols. The platform focuses particularly on complex endoc...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, today announced the appointment of Jeff Busch as Chief Executive Officer of its subsidiary, Ignite Proteomics, LLC (“Ignite” or “Ignite Proteomics”). Ignite Proteomics was recently acquired by Aditxt and operates a commercial-stage precision oncology platform designed to guide cancer therapy selection through functional protein...

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--ClearStrand-ASD today announced it has expanded its age range to include children up to 10 years for autism insights....

ST. LOUIS--(BUSINESS WIRE)--C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, highlighted the first use of its eMTBR-tau243 plasma assay in a Phase 3 dataset (Evoke/Evoke+), reflecting ongoing interest in tau-related signals within Alzheimer’s disease research. The data were presented at the AD/PD™ 2026 Alzheimer's & Parkinson's Diseases Conference during the Evoke/Evoke+ Trial Symposium, which focused on Evoke and Evoke+ cereb...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Fauna Bio, a biotechnology company pioneering the use of extreme mammal biology and comparative genomics to discover novel therapeutic targets, today announced the designation of a target under its strategic obesity discovery collaboration with Eli Lilly and Company (Lilly), initiated in December, 2023. The designated target, identified using Fauna Bio’s proprietary Convergence™ AI platform, represents a potential first-in-class approach to treating obesity...

WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics launches Dyno Psi-Phi, an agentic AI suite for protein binder design, at NVIDIA GTC 2026...